14:33 13/11/2014 Why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is Rising?
Why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is Rising?
Inside Trade - Nov 13, 2014
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) surged as much as 6.6%. It was a welcome reprieve for Arena shareholders, who had seen the stock lose 25% of its value this year before today's gains.
Arena Pharmaceuticals (ARNA) Shares March Higher, Can It Continue? - Zacks.com
Geron Corp (NASDAQ:GERN) Skyrockets on Unusual Volume - Arena ... - StreetWise Report

16:15 11/11/2014 Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?
Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?
Motley Fool - Nov 11, 2014
The new generation of diet pills approved by the Food and Drug Administration have stumbled out of the gate. Specifically, Arena Pharmaceuticals' (NASDAQ: ARNA ) Belviq and VIVUS's (NASDAQ: VVUS ) Qsymia reported a combined 283,000 prescriptions ...
Arena And Vivus Investors Need To Watch Orexigen - Seeking Alpha (registration)

2:50 04/11/2014 Arena Pharmaceuticals, Inc. Earnings: Looking for More
Arena Pharmaceuticals, Inc. Earnings: Looking for More
Motley Fool - Nov 4, 2014
Most biotech investor would be happy with 30% quarter-over-quarter prescription growth in a market that didn't grow much. But for Arena Pharmaceuticals' (NASDAQ: ARNA ) Belviq, the growth is coming off such a small base that it's hard to get too excited.
Arena Pharmaceuticals Posts In Line Q3 Loss, Belviq Grows - Zacks.com
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 ... - MarketWatch

15:56 03/11/2014 Arena Pharmaceuticals, Inc., Loews Corporation, and Sysco Corporation ...
Arena Pharmaceuticals, Inc., Loews Corporation, and Sysco Corporation ...
Investorplace.com - Nov 3, 2014
As Capitol Hill keeps its eyes closely trained on November elections, Wall Street's attention is elsewhere as earnings season continues this week.

13:20 22/10/2014 Could Arena Pharmaceuticals Inc. Be Running Out of Money?
Could Arena Pharmaceuticals Inc. Be Running Out of Money?
Motley Fool - Oct 22, 2014
One biotech in particular that investors should be watching the cash burn rate of very closely is Arena Pharmaceuticals (NASDAQ: ARNA ) . With Wall Street not expecting the company to be profitable on annual basis until 2017, it's worth digging beyond ...

11:52 19/09/2014 Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5%
Arena Pharmaceuticals, Inc. (ARNA) Jumps: Stock Rises 9.5%
Zacks.com - Sep 19, 2014
Arena Pharmaceuticals, Inc. (ARNA - Snapshot Report) was a big mover last session, as the company saw its shares rise by nearly 10% on the day.

15:51 17/09/2014 5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know
5 Things Arena Pharmaceuticals, Inc.'s Management Wants You to Know
Motley Fool - Sep 17, 2014
Arena Pharmaceuticals (NASDAQ: ARNA ) held a press conference in conjunction with its second-quarter earnings to let investors know what's happening with its obesity drug Belviq and the rest of its pipeline.
Belviq And Phentermine Study Awes Some Investors - Should It? (ARNA) - Seeking Alpha (registration)

14:10 12/09/2014 Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen ...
Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen ...
Motley Fool - Sep 12, 2014
Arena Pharmaceuticals (NASDAQ: ARNA ) and Orexigen's (NASDAQ: OREX ) novel anti-obesity pills are among three drugs that the FDA has approved for use alongside diet and exercise to promote weight loss.
Orexigen's Contrave Approved by FDA - NBC 7 San Diego
Novo, Orexigen Join Race For Obesity Drugs; Arena-Eisai's Belviq And Vivus's ... - Bidness ETC

14:46 09/09/2014 Why Arena Pharmaceuticals, Inc. Stock Crashed By 31% in 2014
Why Arena Pharmaceuticals, Inc. Stock Crashed By 31% in 2014
Motley Fool - Sep 9, 2014
Since the year began, the SPDR S&P Biotech ETF has soared 22%. By comparison, shareholders in Arena Pharmaceuticals (NASDAQ: ARNA ) have endured a multi-month downtrend, with their stock down 31% year-to-date and underperforming the biotech ...
Arena Pharmaceuticals - A Biotech Value Investment - Seeking Alpha (registration)

22:00 15/07/2014 Arena Pharmaceuticals Inc. Still Down After CEO's Sale
Arena Pharmaceuticals Inc. Still Down After CEO's Sale
Motley Fool - Jul 15, 2014
"Week-over-week prescriptions are increasing. We're very excited about that. And we expect those prescriptions to continue to increase as, yet a larger salesforce, goes into the field in the next few weeks.